Cite
Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-Treatment Patients With Chronic Hepatitis C: An Open-Label Control Study in China.
MLA
Jiaye Liu, et al. “Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-Treatment Patients With Chronic Hepatitis C: An Open-Label Control Study in China.” Journal of Infectious Diseases, vol. 216, no. 3, Aug. 2017, pp. 327–35. EBSCOhost, https://doi.org/10.1093/infdis/jix295.
APA
Jiaye Liu, Shaohui Qiu, Jingjing Lu, Bingyu Yan, Yi Feng, Li Li, Guomin Zhang, Fuzhen Wang, Peng He, Xin Fang, Zhongyu Hu, Xiaofeng Liang, Aiqiang Xu, Li Zhang, Liu, J., Qiu, S., Lu, J., Yan, B., Feng, Y., & Li, L. (2017). Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-Treatment Patients With Chronic Hepatitis C: An Open-Label Control Study in China. Journal of Infectious Diseases, 216(3), 327–335. https://doi.org/10.1093/infdis/jix295
Chicago
Jiaye Liu, Shaohui Qiu, Jingjing Lu, Bingyu Yan, Yi Feng, Li Li, Guomin Zhang, et al. 2017. “Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-Treatment Patients With Chronic Hepatitis C: An Open-Label Control Study in China.” Journal of Infectious Diseases 216 (3): 327–35. doi:10.1093/infdis/jix295.